Kirsten M. Williams, MD; Jason W. Chien, MD, MS; Mark T. Gladwin, MD; Steven Z. Pavletic, MD. JAMA. 2009;302(3):306-314.
With improvements in supportive care, both long-term survival following allogeneic hematopoietic stem cell transplantations (HSCTs) and the indications for this procedure have increased.
Go to JAMA here.
